Wanner C - Search Results

1

Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?

Nauck M, Krämer-Guth A, Bartens W, März W, Wieland H, Wanner C. Nauck M, et al. Among authors: wanner c. Clin Nephrol. 1996 Nov;46(5):319-25. Clin Nephrol. 1996. PMID: 8953121

2

Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.

Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P. Wanner C, et al. Nephrol Dial Transplant. 1995;10(1):75-81. Nephrol Dial Transplant. 1995. PMID: 7724034

3

Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.

Krämer-Guth A, Nauck M, Pavenstädt H, Königer M, Wieland H, Schollmeyer P, Wanner C. Krämer-Guth A, et al. Among authors: wanner c. J Am Soc Nephrol. 1994 Oct;5(4):1081-90. doi: 10.1681/ASN.V541081. J Am Soc Nephrol. 1994. PMID: 7849247

4

Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.

Wanner C, Böhler J, Eckardt HG, Wieland H, Schollmeyer P. Wanner C, et al. Clin Nephrol. 1994 Mar;41(3):138-43. Clin Nephrol. 1994. PMID: 8187355 Clinical Trial.

5

Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.

Bartens W, Nauck M, Schollmeyer P, Wanner C. Bartens W, et al. Among authors: wanner c. Perit Dial Int. 1996 Jan-Feb;16(1):27-33. Perit Dial Int. 1996. PMID: 8616169

6

Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.

Wanner C, Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Schollmeyer P. Wanner C, et al. Miner Electrolyte Metab. 1996;22(1-3):39-46. Miner Electrolyte Metab. 1996. PMID: 8676822

7

Potential role of lipids in the progression of diabetic nephropathy.

Krämer-Guth A, Quaschning T, Greiber S, Wanner C. Krämer-Guth A, et al. Among authors: wanner c. Clin Nephrol. 1996 Oct;46(4):262-5. Clin Nephrol. 1996. PMID: 8905213 Review.

8

Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells.

Krämer-Guth A, Quaschning T, Pavenstädt H, Galle J, Nauck M, Baumstark MW, Schollmeyer P, März W, Wanner C. Krämer-Guth A, et al. Among authors: wanner c. Nephrol Dial Transplant. 1997 Jul;12(7):1336-43. doi: 10.1093/ndt/12.7.1336. Nephrol Dial Transplant. 1997. PMID: 9249767

9

Effective hypolipidaemic therapy with beclobrate in haemodialysis patients: interference with L-carnitine.

Wanner C, Wieland H, Nauck M, Schaeffer G, Schollmeyer P, Hörl WH. Wanner C, et al. Nephrol Dial Transplant. 1990;5(8):588-93. doi: 10.1093/ndt/5.8.588. Nephrol Dial Transplant. 1990. PMID: 23275992 Clinical Trial.

10

Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.

Wanner C, Lubrich-Birkner I, Summ O, Wieland H, Schollmeyer P. Wanner C, et al. Nephron. 1992;62(1):40-6. doi: 10.1159/000186993. Nephron. 1992. PMID: 1436290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,046 results

Search Page

Filters